clinical trials bpc-157 human evidence review safety regulatory status Gastric pentadecapeptide body protection compound BPC BPC-157 Human Trial: 87.5% of
Description
Experts believe that Alzheimer's dementia, like other common chronic diseases and conditions, likely develops as a result of multiple factors
Do not use in animals with diarrhoea
doi: 10.1016/S0169-409X(97)00067-7
While not a surgical substitute, peptide therapy can reduce the need for invasive procedures by promoting natural tissue healing and pain relief over time
For how it sits alongside the other compounds in its class, see the tissue-repair peptides overview
